Move clinical trial data sharing from an option to an imperative - STAT

peter.suber's bookmarks 2019-02-27


"From Jan. 1, 2019, onward, the world’s leading medical journals, including the New England Journal of Medicine, the Lancet, Annals of Internal Medicine, BMJ, and thousands more require authors to disclose whether and how they plan to share deidentified raw data from individual participants in their clinical trials. What’s more, researchers wishing to publish in these journals must declare their data-sharing plans in a public registry, such as

It’s a radical departure from where we’ve been. ...

There are also rewards for the researchers who share data. They can be more widely recognized for their hard work. Those who share data receive more citations from other researchers. It’s a reward system that builds on itself: As the number of papers that reuse a data set grows, the more citations a researcher receives. This takes on even more significance with the International Committee of Medical Journal Editors requirements, as editors have indicated they “may take into consideration data sharing statements when making editorial decisions.” ..."



From feeds:

Open Access Tracking Project (OATP) » peter.suber's bookmarks

Tags: oa.medicine oa.pharma oa.benefits oa.advantage oa.mandates oa.recommendations oa.journals oa.policies

Date tagged:

02/27/2019, 13:06

Date published:

02/27/2019, 08:06